392 related articles for article (PubMed ID: 26968393)
1. Vascular Complications of Cancer Chemotherapy.
Cameron AC; Touyz RM; Lang NN
Can J Cardiol; 2016 Jul; 32(7):852-62. PubMed ID: 26968393
[TBL] [Abstract][Full Text] [Related]
2. [Vascular Complications Of Cancer Chemotherapy].
Belenkov YN; Privalova EV; Kozhevnikova MV; Kirichenko YY
Kardiologiia; 2018 Sep; 58(Suppl 9):4-9. PubMed ID: 30312566
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular toxic effects of antitumor agents: Pathogenetic mechanisms.
Pantazi D; Tselepis AD
Thromb Res; 2022 May; 213 Suppl 1():S95-S102. PubMed ID: 36210569
[TBL] [Abstract][Full Text] [Related]
4. Insights into cardiovascular side-effects of modern anticancer therapeutics.
Stortecky S; Suter TM
Curr Opin Oncol; 2010 Jul; 22(4):312-7. PubMed ID: 20535072
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.
Hassan SA; Palaskas N; Kim P; Iliescu C; Lopez-Mattei J; Mouhayar E; Mougdil R; Thompson K; Banchs J; Yusuf SW
Curr Atheroscler Rep; 2018 Feb; 20(2):10. PubMed ID: 29423705
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular side-effects of modern cancer therapy.
Minami M; Matsumoto S; Horiuchi H
Circ J; 2010 Sep; 74(9):1779-86. PubMed ID: 20716834
[TBL] [Abstract][Full Text] [Related]
7. Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association.
Cohen JB; Brown NJ; Brown SA; Dent S; van Dorst DCH; Herrmann SM; Lang NN; Oudit GY; Touyz RM;
Hypertension; 2023 Mar; 80(3):e46-e57. PubMed ID: 36621810
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
Yeh ET; Bickford CL
J Am Coll Cardiol; 2009 Jun; 53(24):2231-47. PubMed ID: 19520246
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
Maurea N; Coppola C; Piscopo G; Galletta F; Riccio G; Esposito E; De Lorenzo C; De Laurentiis M; Spallarossa P; Mercuro G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S19-26. PubMed ID: 27183521
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.
Moudgil R; Yeh ET
Can J Cardiol; 2016 Jul; 32(7):863-870.e5. PubMed ID: 27117975
[TBL] [Abstract][Full Text] [Related]
11. The prevention and management of cardiovascular complications of chemotherapy in patients with cancer.
Youssef G; Links M
Am J Cardiovasc Drugs; 2005; 5(4):233-43. PubMed ID: 15984906
[TBL] [Abstract][Full Text] [Related]
12. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Steingart RM; Bakris GL; Chen HX; Chen MH; Force T; Ivy SP; Leier CV; Liu G; Lenihan D; Lindenfeld J; Maitland ML; Remick SC; Tang WH
Am Heart J; 2012 Feb; 163(2):156-63. PubMed ID: 22305831
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?
Herrmann J
Curr Oncol Rep; 2016 Jun; 18(6):33. PubMed ID: 27099141
[TBL] [Abstract][Full Text] [Related]
15. Vascular effects of cancer treatments.
Campia U
Vasc Med; 2020 Jun; 25(3):226-234. PubMed ID: 32539632
[TBL] [Abstract][Full Text] [Related]
16. Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome.
Small HY; Montezano AC; Rios FJ; Savoia C; Touyz RM
Can J Cardiol; 2014 May; 30(5):534-43. PubMed ID: 24786444
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
18. Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.
Herrmann J; Yang EH; Iliescu CA; Cilingiroglu M; Charitakis K; Hakeem A; Toutouzas K; Leesar MA; Grines CL; Marmagkiolis K
Circulation; 2016 Mar; 133(13):1272-89. PubMed ID: 27022039
[TBL] [Abstract][Full Text] [Related]
19. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients.
van Dorst DCH; Dobbin SJH; Neves KB; Herrmann J; Herrmann SM; Versmissen J; Mathijssen RHJ; Danser AHJ; Lang NN
Circ Res; 2021 Apr; 128(7):1040-1061. PubMed ID: 33793337
[TBL] [Abstract][Full Text] [Related]
20. Vascular complications of selected cancer therapies.
Daher IN; Yeh ET
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):797-805. PubMed ID: 18852710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
